By Andrew Hayley BEIJING (Reuters) – China’s muted economic growth in 2023 as its post-COVID recovery underwhelms has crimped the outlook for demand for...
ANKARA (Reuters) -Turkey’s central bank began rolling back on Sunday a growing and costly scheme that protects lira deposits from FX depreciation, marking another...
By Brenda León Neurocrine Biosciences said Friday the Food and Drug Administration approved Ingrezza capsules to treat adults with chorea, an abnormal involuntary movement...